2012 - Europe Direct Iasi
2012 - Europe Direct Iasi
2012 - Europe Direct Iasi
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
EUROINVENT <strong>2012</strong><br />
4.14.<br />
Title Method for diagnosing the severity of reflux oesophagitis<br />
SCORPAN Anatolie, MD; BIVOL Grigorii, MD; SCURTU<br />
Authors<br />
Alina, MD; SCURTU Serghei, MD;<br />
Institution AGEPI MD<br />
Patent no. Nr.2160/2003<br />
The invention relates to medicine, namely to gastroenterology.<br />
Method for diagnosing the severity of reflux oesophagitis<br />
including by esofagoscopiei, characterized in that it is<br />
determined during propagation peristalticii portion of the<br />
Description esophagus that starts at the spring aorta and ends esogastrice and<br />
reached the junction where the propagation time peristalticii is<br />
6.0 ± 0.3 s, diagnosed mild severity, and 10.80 ± 0.65 - 14.80 ±<br />
0.46 and the average severity and -extremely serious condition of<br />
reflux oesophagitis.<br />
4.15.<br />
Title Method of treatment of chronic C hepatitis<br />
BODRUG Nicolae, MD; RUDIC Valeriu, MD; BUTOROV<br />
Authors Ivan, MD; ANTONOVA Natalia, MD; TIBERNEAC Maia, MD;<br />
ISTRATE Viorel, MD; SCORPAN Anatolie, MD<br />
Institution AGEPI MD<br />
Patent no. Nr. 3477/2008<br />
The invention relates to medicine, namely to hepatology and is<br />
intended for the treatment of chronic hepatitis C.<br />
Method, the invention consists in that it is given 300 ... 400 ml<br />
0.9% NaCl solution ozonated containing 4 ... 5 mg / L ozone,<br />
Description<br />
intravenous drops a day for 10 ... 12 sessions in a series and<br />
simultaneously daily administered spasmolytic, hepatoprotective<br />
amino acids in normal daily dose. After completing the series in<br />
5 ... 6 months is given a hepatoprotective. However, treatment is<br />
performed at least three years.<br />
4.16.<br />
Therapeutic strategies for innovative anti-ageing cosmeceuticals,<br />
Title<br />
based on fully exploitation of three species of Romanian<br />
medicinal plants<br />
Authors Brandusa Dumitriu, Laura Olariu, Lenus Zglimbea<br />
Institution SC Biotehnos SA<br />
Patent no. pending<br />
Description<br />
The correct definition of the cellular / molecular target<br />
for the dermato-cosmetic claim is an important step in cosmetic<br />
product design. In order to fulfill this request, modern techniques<br />
are performed starting with advanced gene research and<br />
continuing with structural protein characterization, intra / extra<br />
cellular signaling pathways, etc. The development of these new<br />
Class 4<br />
81